Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes
Tóm tắt
Từ khóa
Tài liệu tham khảo
Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179–183
DCCT research group (1993) The effect of intensive treatment of diabetes on development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329:977–986
UK Prospective Diabetes Study group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837–853
Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN (2008) Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited. Diabetes 57:995–1001
Chang CM, Hsieh CJ, Huang JC, Huang IC (2012) Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. doi: 10.1007/s00592-012-0398-x
Nalysnyk L, Hernandez-Medina M, Krishnarajah G (2010) Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab 12:288–298
Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH (2010) Glucose variability: does it matter? Endocr Rev 31:171–182
De Block C, Manuel-y-Keenoy B, Van Gaal L (2008) A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol 2:718–727
Hoekstra JB, Nathan DMJ, Borg R, Zheng H, Schoenfeld D, Heine RJ for the A1c-Derived Average Glucose (ADAG) Study Group (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31:1473–1478
Sartore G, Chilelli NC, Burlina S, Stefano PD, Piarulli F, Fedele D, Mosca A, Lapolla A (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetol. doi: 10.1007/s00592-012-0391-4
Klonoff DC (2005) Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 28:1231–1239
Ceriello A, Ihnat MA (2010) ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting. Diabet Med 27:862–867
Rodbard D (2009) New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 11:551–565
Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644–656
McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 7:253–263
Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W (2006) Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29:2433–2438
Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Arlie house classification. ETDRS report number 10. Ophtalmology 98:786–806
Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682
Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW on behalf of the DPV–Wiss Study Group (2011) Diabetic retinopathy in type 1 diabetes—a contemporary analysis of 8,784 patients. Diabetologia 54:1977–1984
Kempen JH, O’ Colmain BJ, Leske MC et al (2004) The prevalence of diabetic retinopathy among adults in the United States. Arch Ophtalmol 122:552–563
Bolli GB, Andreoli AM, Lucidi P (2011) Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era. Diabetes Technol Ther 13:S43–S52
Stolar M (2010) Glycemic control and complications in type 2 diabetes mellitus. The American Journal of Medicine 123:S3–S11
Kohnert KD, Augstein P, Zander E, Heinke P, Peterson K, Freise EJ et al (2009) Glycemic variability correlates strongly with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 32:1058–1062
Lam CSY, Benzie IFF, Choi SW, Chan LYL, Yeung VTF, Woo GC (2011) Relationships among diabetic retinopathy, antioxidants, and glycemic control. Optom Vis Sci 88:251–256
Monnier L, Colette C, Owens D (2012) The glycemic triumvirate and diabetic complications: is the whole greater than the sum of its component parts? Diabetes Res Clin Pract 95:303–311
Kilpatrick ES, Rigby AS, Atkin SL (2009) Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 32:1901–1903
Zoppini G, Verlato G, Targer G et al (2008) Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? NMCD 19:334–339
Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y (2011) The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients. Diabetes Res Clin Pract 91:e40–e42
Patton SR, Midyett LK, Dolan LM, Powers SW (2011) A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous monitoring and self-monitoring data. Diabetes Technol Ther 14:239–243
Vazeou A (2011) Continuous blood glucose monitoring in diabetes treatment. Diabetes Res Clin Pract 93:S125–S130
Monnier L, Colette C, Owens DR (2008) Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol 2:1094–1100